MK
Matthew R. Kwietniak
Chief Commercial Officer

Matthew R. Kwietniak insider trades: Avid Bioservices (CDMO) stock sales

Chief Commercial Officer, Avid Bioservices Last trade Dec 26, 2024 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2023
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Matthew reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 26, 2024CDMO↓ Sell$164K
Oct 14, 2024CDMO↓ Sell$1K
Oct 10, 2024CDMO↓ Sell$10K
Jul 15, 2024CDMO↓ Sell$3K
Jul 12, 2024CDMO↓ Sell$958
Jul 10, 2024CDMO↓ Sell$3K
Apr 30, 2024CDMO↓ Sell$9K
Jan 12, 2024CDMO↓ Sell$2K
Jan 10, 2024CDMO↓ Sell$7K
Oct 12, 2023CDMO↓ Sell$2K
Oct 10, 2023CDMO↓ Sell$9K
Jul 12, 2023CDMO↓ Sell$3K
Jul 10, 2023CDMO↓ Sell$7K
Jun 29, 2023CDMO↓ Sell$50K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Matthew R. Kwietniak's insider trades

Matthew R. Kwietniak is Chief Commercial Officer at Avid Bioservices (CDMO). Since Jun 29, 2023, Matthew has reported no open-market purchases and 14 sales worth $270K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (15 filings), shares returned to the company (6 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CDMO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.